{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:28Z","timestamp":1793949568712,"version":"4.8.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["CVON 2017-20"],"award-info":[{"award-number":["CVON 2017-20"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cmet.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:38:00Z","timestamp":1718361480000},"page":"1534-1549.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor"],"prefix":"10.1016","volume":"36","author":[{"given":"Ajit","family":"Regmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Christe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libbey S.","family":"O\u2019Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Bellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Konkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Wojnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne K.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Estelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Badger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel S.","family":"Gaidosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Kooijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-6217","authenticated-orcid":false,"given":"William","family":"Roell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2024.05.010_bib1","series-title":"IDF Diabetes Atlas","year":"2021"},{"key":"10.1016\/j.cmet.2024.05.010_bib2","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual gip and glp-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2024.05.010_bib3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/dom.14174","article-title":"The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes","volume":"22","author":"Wilson","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2024.05.010_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cmet.2024.05.010_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2024.05.010_bib7","first-page":"912","article-title":"Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7\u201336) amide infused at near-physiological insulinotropic hormone and glucose concentrations","volume":"76","author":"Nauck","year":"1993","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/db18-1123","article-title":"Separate and combined glucometabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals","volume":"68","author":"Gasbjerg","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cmet.2024.05.010_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101171","article-title":"Whole-brain activation signatures of weight-lowering drugs","volume":"47","author":"Hansen","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.regpep.2007.02.006","article-title":"GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women","volume":"142","author":"Rudovich","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cmet.2024.05.010_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tem.2020.02.006","article-title":"How may GIP enhance the therapeutic efficacy of GLP-1?","volume":"31","author":"Samms","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db21-1166","article-title":"GIPR is predominantly localized to nonadipocyte cell types within white adipose tissue","volume":"71","author":"Campbell","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41574-022-00783-3","article-title":"Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1","volume":"19","author":"Hammoud","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2024.05.010_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/endo.140.1.6464","article-title":"Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin","volume":"140","author":"McIntosh","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2024.05.010_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/oby.2006.129","article-title":"Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification","volume":"14","author":"Getty-Kaushik","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cmet.2024.05.010_bib19","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00100.2012","article-title":"Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes","volume":"304","author":"Timper","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/ijo.2008.148","article-title":"Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model","volume":"32","author":"Weaver","year":"2008","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.cmet.2024.05.010_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2020.08.011","article-title":"GIP(3-30)NH2 - a tool for the study of GIP physiology","volume":"55","author":"Lynggaard","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cmet.2024.05.010_bib22","first-page":"3575","article-title":"Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide","volume":"85","author":"Deacon","year":"2000","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2024.05.010_bib25","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/dom.14110","article-title":"The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists","volume":"22","author":"Urva","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cmet.2024.05.010_bib28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0016-5085(74)80134-4","article-title":"Radioimmunoassay for gastric inhibitory polypeptide","volume":"66","author":"Kuzio","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.010_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.regpep.2004.06.020","article-title":"Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes","volume":"122","author":"Nauck","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cmet.2024.05.010_bib31","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1053\/j.gastro.2007.09.005","article-title":"Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation","volume":"133","author":"Song","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.010_bib32","doi-asserted-by":"crossref","first-page":"43062","DOI":"10.1074\/jbc.M111.289009","article-title":"Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110\u03b2 isoform of phosphatidylinositol 3-kinase","volume":"286","author":"Mohammad","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.010_bib33","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2337\/db10-0098","article-title":"Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans","volume":"59","author":"Asmar","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib34","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ncomms2537","article-title":"De novo lipogenesis in human fat and liver is linked to ChREBP-\u03b2 and metabolic health","volume":"4","author":"Eissing","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.05.010_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1194\/jlr.M052860","article-title":"In\u00a0vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans","volume":"56","author":"Allister","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cmet.2024.05.010_bib36","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/s41598-017-09450-4","article-title":"Glycerol is synthesized and secreted by adipocytes to dispose of excess glucose, via glycerogenesis and increased acyl-glycerol turnover","volume":"7","author":"Rotondo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2024.05.010_bib37","doi-asserted-by":"crossref","first-page":"27565","DOI":"10.1074\/jbc.M804393200","article-title":"Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in\u00a0vivo in the rat","volume":"283","author":"Nye","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.010_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2006.00590.x","article-title":"Ectopic fat accumulation and metabolic syndrome","volume":"9","author":"Rasouli","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1042\/BST0360935","article-title":"Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese","volume":"36","author":"Tan","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cmet.2024.05.010_bib41","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1194\/jlr.R200015-JLR200","article-title":"Lipoprotein lipase: genetics, lipid uptake, and regulation","volume":"43","author":"Merkel","year":"2002","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cmet.2024.05.010_bib42","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1194\/jlr.C070946","article-title":"Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes","volume":"57","author":"Hegele","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cmet.2024.05.010_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-021-00918-3","article-title":"Lipid lowering drugs: present status and future developments","volume":"23","author":"Ruscica","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cmet.2024.05.010_bib44","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M609088200","article-title":"Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade","volume":"282","author":"Kim","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.010_bib45","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1194\/jlr.M006841","article-title":"GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene","volume":"51","author":"Kim","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cmet.2024.05.010_bib46","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1152\/ajpendo.00347.2016","article-title":"Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response","volume":"312","author":"Thondam","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1590\/2359-3997000000067","article-title":"Lipolysis and lipases in white adipose tissue\u2014an update","volume":"59","author":"Bolsoni-Lopes","year":"2015","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2337\/db14-0440","article-title":"Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes","volume":"64","author":"Christensen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/dom.14545","article-title":"Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: A randomized, double-blind, placebo-controlled, crossover clinical trial","volume":"24","author":"Heimburger","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.cmet.2024.05.010_bib50","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0021-9150(98)00216-0","article-title":"Non-esterified fatty acid metabolism and postprandial lipaemia","volume":"141","author":"Frayn","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cmet.2024.05.010_bib51","doi-asserted-by":"crossref","first-page":"209ra151","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cmet.2024.05.010_bib52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/db16-0758","article-title":"Inhibition of gastric inhibitory polypeptide receptor signaling in adipose tissue reduces insulin resistance and hepatic steatosis in high-fat diet-fed mice","volume":"66","author":"Joo","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s42255-018-0001-z","article-title":"GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8\/A9","volume":"1","author":"Mantelmacher","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.05.010_bib54","series-title":"A study of LY3532226 in healthy participants","year":"2000"},{"key":"10.1016\/j.cmet.2024.05.010_bib56","series-title":"A study of LY3537021 in healthy participants and participants with type 2 diabetes mellitus","year":"2000"},{"issue":"Suppl 1","key":"10.1016\/j.cmet.2024.05.010_bib57","article-title":"56-OR: a long-acting glucose-dependent insulinotropic polypeptide receptor agonist shows weight loss without nausea or vomiting","volume":"72","author":"Knop","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.010_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-61779-367-7_14","article-title":"Culture of isolated human adipocytes and isolated adipose tissue","volume":"806","author":"Carswell","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cmet.2024.05.010_bib59","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1194\/jlr.D010744","article-title":"Determination of lipoprotein lipase activity using a novel fluorescent lipase assay","volume":"52","author":"Basu","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cmet.2024.05.010_bib60","unstructured":"Affymetrix. Microarray normalization using signal space transformation with probe guanine cytosine count correction. A White Paper from the Affymetrix. http:\/\/tools.thermofisher.com\/content\/sfs\/brochures\/sst_gccn_whitepaper.pdf."},{"key":"10.1016\/j.cmet.2024.05.010_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on bias and variance","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmet.2024.05.010_bib62","series-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"key":"10.1016\/j.cmet.2024.05.010_bib63","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0022-2275(20)37190-X","article-title":"Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in\u00a0vivo","volume":"38","author":"Rensen","year":"1997","journal-title":"J.\u00a0Lipid Res."}],"updated-by":[{"DOI":"10.1016\/j.cmet.2024.06.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000}}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:41:13Z","timestamp":1731721273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413124001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1550413124001864"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2024.05.010","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Eli Lilly and Company. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}